SCHEMBL26679983

SCHEMBL26679983

O=c1ccc2c(-c3cccc(N[SH](=O)=O)c3)ccnc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 10/20 0.43
▸ PRKCI P41743 1/20 0.40
▸ CHUK O15111 3/20 0.39
▸ IKBKB O14920 2/20 0.39
▸ MAPK8 P45983 2/20 0.39
▸ INSR P06213 1/20 0.39
▸ CAMKK2 Q96RR4 1/20 0.39
▸ PIK3C3 Q8NEB9 1/20 0.38
▸ PDE3B Q13370 2/20 0.37
▸ PDE3A Q14432 2/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ JAK3 P52333 2/20 0.37
▸ CDK9 P50750 2/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ PRKD3 O94806 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ PAK4 O96013 1/20 0.37
▸ CSF1R P07333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL26680010 0.99 NUDT1 (0.42) NUDT1PRKCICHUKIKBKBMAPK8
SCHEMBL26679934 0.84 IKBKB (0.42) CHUKIKBKBMAPK8INSRCAMKK2
SCHEMBL24600505 0.81 NUDT1 (0.42) NUDT1PRKCICHUKIKBKBMAPK8
SCHEMBL29691588 0.81 ENPP1 (0.53) NUDT1PRKCICHUKIKBKBMAPK8
SCHEMBL24600506 0.81 ENPP1 (0.53) NUDT1PRKCICHUKIKBKBMAPK8
Hydrochloric Acid SCHEMBL26680014 0.81 ENPP1 (0.54) NUDT1PRKCICHUKIKBKBMAPK8
Hydrochloric Acid SCHEMBL29691657 0.81 ENPP1 (0.54) NUDT1PRKCICHUKIKBKBMAPK8
SCHEMBL26679905 0.80 NUDT1 (0.40) NUDT1PRKCICHUKIKBKBMAPK8
SCHEMBL24600955 0.79 CDK9 (0.47) NUDT1PRKCICHUKIKBKBMAPK8
Hydrochloric Acid SCHEMBL26679902 0.79 PTK6 (0.41) ACVR1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140944-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF TXINNO BIOSCIENCE INC. (KR) 2024-05-02 — — US claimed
EP-4276100-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF Txinno Bioscience Inc. (KR) 2023-11-15 — — EP claimed
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN claimed
US-20240140944-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF TXINNO BIOSCIENCE INC. (KR) 2024-05-02 — — US disclosed
EP-4276100-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF Txinno Bioscience Inc. (KR) 2023-11-15 — — EP disclosed
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240140944-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF ENPP1, ENPP3, ENTPD5 NUDT1 53/4885PRKCI 1640/4885CHUK 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback